121 related articles for article (PubMed ID: 26194926)
1. William Klunk: imaging Alzheimer's disease in vivo.
Kirby T
Lancet Neurol; 2015 Aug; 14(8):791. PubMed ID: 26194926
[No Abstract] [Full Text] [Related]
2. PET and 18F ligands in the diagnosis of Alzheimer's disease.
Frisoni GB
Lancet Neurol; 2011 May; 10(5):397-9. PubMed ID: 21481641
[No Abstract] [Full Text] [Related]
3. Whatever happened to Pittsburgh Compound-A?
Klunk WE; Mathis CA
Alzheimer Dis Assoc Disord; 2008; 22(3):198-203. PubMed ID: 18769172
[No Abstract] [Full Text] [Related]
4. Bruno Dubois: transforming the diagnosis of Alzheimer's disease.
Holmes D
Lancet Neurol; 2014 Jun; 13(6):541. PubMed ID: 24849858
[No Abstract] [Full Text] [Related]
5. Review of The Alzheimer's Conundrum by Margaret Lock.
George DR; Whitehouse PJ
Cult Med Psychiatry; 2016 Jun; 40(2):299-306. PubMed ID: 27075567
[No Abstract] [Full Text] [Related]
6. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease in the 100 years since Alzheimer's death.
Ryan NS; Rossor MN; Fox NC
Brain; 2015 Dec; 138(Pt 12):3816-21. PubMed ID: 26541346
[No Abstract] [Full Text] [Related]
8. Lessons in the study of Alzheimer's disease: a tribute to Dr. William R. Markesbery.
Bruce-Keller AJ; Keller JN
Neuromolecular Med; 2011 Mar; 13(1):11-4. PubMed ID: 20640533
[No Abstract] [Full Text] [Related]
9. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
Villeneuve S; Rabinovici GD; Cohn-Sheehy BI; Madison C; Ayakta N; Ghosh PM; La Joie R; Arthur-Bentil SK; Vogel JW; Marks SM; Lehmann M; Rosen HJ; Reed B; Olichney J; Boxer AL; Miller BL; Borys E; Jin LW; Huang EJ; Grinberg LT; DeCarli C; Seeley WW; Jagust W
Brain; 2015 Jul; 138(Pt 7):2020-33. PubMed ID: 25953778
[TBL] [Abstract][Full Text] [Related]
10. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
[TBL] [Abstract][Full Text] [Related]
11. William R. Markesbery, M.D.: A legacy of excellence in Alzheimer's disease research and a life well-lived.
Butterfield DA
J Alzheimers Dis; 2010; 20(1):3-4. PubMed ID: 20378955
[No Abstract] [Full Text] [Related]
12. Alzheimer's disease: will advances made in the past turn the tide?
Semla TP
Ann Pharmacother; 2007 Sep; 41(9):1494-6. PubMed ID: 17666576
[No Abstract] [Full Text] [Related]
13. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
14. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease.
Barnett R
Lancet; 2019 Apr; 393(10181):1589. PubMed ID: 31007191
[No Abstract] [Full Text] [Related]
16. PET and MR show promise in diagnosing Alzheimer disease.
Radiol Technol; 2004; 76(1):80-2. PubMed ID: 15503725
[No Abstract] [Full Text] [Related]
17. A quarter century of advancing treatment for Alzheimer's disease with Leon J. Thal.
Grundman M
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S51-5. PubMed ID: 18632001
[No Abstract] [Full Text] [Related]
18. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
[TBL] [Abstract][Full Text] [Related]
19. Current and future treatments for Alzheimer's disease.
Salloway S
CNS Spectr; 2009 Aug; 14(8 Suppl 7):4-7; discussion 16-8. PubMed ID: 19890240
[TBL] [Abstract][Full Text] [Related]
20. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden.
Banerjee G; Kim HJ; Fox Z; Jäger HR; Wilson D; Charidimou A; Na HK; Na DL; Seo SW; Werring DJ
Brain; 2017 Apr; 140(4):1107-1116. PubMed ID: 28335021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
